EIF4EBP1 and cancer: mTORC1, a validated cancer drug target, regulates protein translation through its substrates S6K1 and 4E-BP1 as well as anabolic metabolism downstream of growth factor receptor-activated PI3K-AKT signaling and in response to amino acid nutrient levels [36, 37].